Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 2103-2107, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lempinen, M.
Right arrow Articles by Kemppainen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lempinen, M.
Right arrow Articles by Kemppainen, E.
Related Collections
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2001;47:2103-2107.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

Predicting the Severity of Acute Pancreatitis by Rapid Measurement of Trypsinogen-2 in Urine

Marko Lempinen1, Marja-Leena Kylänpää-Bäck1, Ulf-Håkan Stenman2, Pauli Puolakkainen1, Reijo Haapiainen1, Patrik Finne2, Armi Korvuo3 and Esko Kemppainen1a

1 Second Department of Surgery and
2 Department of Clinical Chemistry, University Central Hospital Helsinki, Haartmaninkatu 4, FIN-00290 Helsinki, Finland.

3 Medix Biochemica, FIN-02700 Kauniainen, Finland.

aAuthor for correspondence. Fax 358-9-47174675; e-mail esko.kemppainen{at}hus.fi.

Background: Early identification of patients at risk of developing a severe attack of acute pancreatitis (AP) is of great importance because rapid therapeutic interventions improve outcome. At a cutoff of 50 µg/L, trypsinogen-2 measured by a rapid urinary dipstick is a sensitive and specific diagnostic test in AP. The trypsinogen-2 concentration correlates with the severity of the disease, and a test with a higher cutoff might therefore be useful for prediction of disease severity.

Methods: We increased the detection limit of the urinary trypsinogen-2 test strip (Actim Pancreatitis) from 50 µg/L to 2000 µg/L and evaluated the prognostic value of this test. The results were compared with those obtained with serum C-reactive protein and the acute physiology and chronic health evaluation II (APACHE II) score. The study population consisted of 150 consecutive patients with AP (42 with severe disease).

Results: The sensitivity of the rapid urinary test strip (detection limit, 2000 µg/L) for prediction of severe AP, both on admission and at 24 h, was 62%; specificities were 87% and 85%, respectively, positive predictive values were 65% and 62%, and negative predictive values were 85% and 85%. C-Reactive protein had a sensitivity of only 38% on admission, but at 24 h, it was 83%; specificities were 90% and 70%, respectively, whereas positive predictive values were 59% and 52%, and NPVs were 79% and 91%, respectively. On admission the positive-likelihood ratio for the urinary trypsinogen-2 test strip was 4.8, and at 24 h it was 4.2; for C-reactive protein, the values were 3.7 and 2.7, respectively.

Conclusions: The urinary trypsinogen-2 dipstick is a simple and rapid method for prediction of severe acute pancreatitis.




The following articles in journals at HighWire Press have cited this article:


Home page
Toxicol SciHome page
J. L. Walgren, M. D. Mitchell, L. O. Whiteley, and D. C. Thompson
Identification of Novel Peptide Safety Markers for Exocrine Pancreatic Toxicity Induced by Cyanohydroxybutene
Toxicol. Sci., March 1, 2007; 96(1): 174 - 183.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
W R Matull, S P Pereira, and J W O'Donohue
Biochemical markers of acute pancreatitis.
J. Clin. Pathol., April 1, 2006; 59(4): 340 - 344.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Lumbreras-Lacarra, J. M. Ramos-Rincon, and I. Hernandez-Aguado
Methodology in Diagnostic Laboratory Test Research in Clinical Chemistry and Clinical Chemistry and Laboratory Medicine
Clin. Chem., March 1, 2004; 50(3): 530 - 536.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.